AGC’s Three Part Webinar Series on Navigating the Complexities of Marijuana, CBD and Opioid Use in Construction
Part 1: October 1, 2019 | Part 2: October 8, 2019 | Part 3: October 15, 2019
2:00 PM - 3:00 PM EDT
Member Price: $149| Non Member Price: $199
Part One: Marijuana in the Workplace
In 33 states the medical use of marijuana has been legalized. Eleven states have passed laws authorizing the personal, adult-use of marijuana and 18 states have authorized the use of CBD. This does not consider the growing legalization of hemp and hemp-based products such as CBD.
What are the workplace ramifications of this increased use of marijuana and CBD? Are employers limited in acting against an employee or applicant who claims to use marijuana legally but tests positive for marijuana?
Part Two: Cannabidiol (CBD) Use and the Workplace
What is CBD? How is it different from marijuana? If an employee uses it will they get high? Will they test positive on a workplace drug test? How does the new Farm Bill impact the legalization of CBD?
Part Three: The Opioid Crisis
Is there anyone, any workplace that is unaffected by the opioid crisis? According to the latest statistics from the Centers for Disease Control, more than 115 Americans die every day from an opioid overdose. There are enough opioids prescribed every year in this country so that each American, man woman and child could have one.